EV Biotech Competitors and Similar CompaniesClear all
ReCode Therapeutics's competitors and similar companies include Thousand Oaks Biopharmaceuticals.
 ReCode Therapeutics ReCode Therapeutics is a company developing non-viral nanoparticles for delivery of diverse RNA- and protein-based therapeutics to targeted tissues, and tRNA NanoCorrectors. |  Thousand Oaks Biopharmaceuticals Thousand Oaks Biopharmaceuticals (澳斯康生物制药) is a company that provides contract research and manufacturing services with a focus on cell line development. | |
Founding Date | Founding Date 2015 | Founding Date 2017 |
Type | Type Private | Type Private |
Tags | ||
Locations | Locations Menlo Park, US HQ | Locations Nantong, CN HQ |
Employees | Employees 1062% decrease | Employees 43 |
Funding | ||
Latest funding round | Latest funding round $ 80m (about 6 years ago) | Latest funding round $ 64m (almost 6 years ago) |
Total funding raised | Total funding raised $ 82m | Total funding raised $ 107.6m |
For sources of this data, please see the company profile
View Company Profiles
Thousand Oaks Biopharmaceuticals
HQ
Nantong, CN
Employees
43
Thousand Oaks Biopharmaceuticals (澳斯康生物制药) is a company that provides contract research and manufacturing services with a focus on cell line development.
View company